KOBAYASHI Pharmaceutical
4967.T
$60.75
Share price
-0.44%
Change (1 day)
13.34%
Change (1 year)
Categories
Revenue for KOBAYASHI Pharmaceutical (4967.T)
Revenue in 2024 (TTM): A$1.69 Billion
According to KOBAYASHI Pharmaceutical's latest financial reports the company's current revenue (TTM 
) is A$1.89 Billion. In 2023 the company made a revenue of A$1.78 Billion a decrease over the revenue in the year 2022 that were of A$1.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for KOBAYASHI Pharmaceutical from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | A$1.69 B | -5.25% |
| 2023 | A$1.78 B | -2.28% |
| 2022 | A$1.83 B | -4.11% |
| 2021 | A$1.90 B | 3.15% |
| 2020 | A$1.85 B | -15.02% |
| 2019 | A$2.17 B | 1.14% |
| 2018 | A$2.15 B | 20.42% |
| 2017 | A$1.78 B | |
| 2015 | A$1.54 B | 6.71% |
| 2014 | A$1.44 B | 4.85% |
| 2013 | A$1.38 B | -4.82% |
| 2012 | A$1.45 B | -10.22% |
| 2011 | A$1.61 B | 9.29% |
| 2010 | A$1.47 B | -3.29% |
| 2009 | A$1.52 B |